GlassScriptPhysician profile
Puneet Shroff
NPI 1265645782
$3,812.84
in general payments reported to CMS, 2019-2025
19 companies · $442 in 2025
The $442 reported for 2025 was less than what a typical Allergy & Immunology (Internal Medicine) provider received nationally (typical 2025 total: $681).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $103 · 2021: $430 · 2022: $1,507 · 2023: $311 · 2024: $475 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,068 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,068.21 |
| Education | $160.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,598.71 | 2019-2024 | Nucala |
| Astrazeneca Pharmaceuticals LP | $610.70 | 2019-2025 | Tezspire, Fasenra |
| Amgen INC. | $219.62 | 2023-2025 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $208.02 | 2023-2025 | Cuvitru, Hyqvia |
| Regeneron Healthcare Solutions, INC. | $167.09 | 2019-2025 | Dupixent |
| Genzyme Corporation | $164.11 | 2019-2021 | |
| Kls-Martin L.P. | $144.59 | 2024 | |
| Biocryst US Sales Co., LLC | $125.00 | 2021 | |
| Shire North American Group INC | $124.18 | 2019 | |
| Novartis Pharmaceuticals Corporation | $92.46 | 2022-2025 | |
| Grifols USA, LLC | $71.18 | 2019-2024 | Xembify |
| Stryker Corporation | $59.42 | 2020 | |
| Genentech, INC. | $57.57 | 2019 | |
| Ucb, INC. | $51.03 | 2024 | |
| Regeneron Pharmaceuticals, INC. | $44.00 | 2023 | Dupixent |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $28.96 | 2019-2022 | |
| Bio Products Laboratory USA, INC. | $16.78 | 2023 | Gammaplex, Coagadex |
| Leo Pharma INC. | $14.94 | 2025 | Adbry |
| Galderma Laboratories, L.P. | $14.48 | 2025 | Nemluvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Puneet Shroff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.